|Bid||143.65 x 100|
|Ask||147.46 x 100|
|Day's Range||143.83 - 145.27|
|52 Week Range||106.48 - 148.84|
|PE Ratio (TTM)||32.61|
|Dividend & Yield||1.70 (1.18%)|
|1y Target Est||N/A|
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Stryker's (SYK) diverse product portfolio alongside acquisition-driven strategy would continue to boost growth prospects. However, competition in the Chinese market raise concern.
Accuray's (ARAY) Radixact system leverages on its flagship TomoTherapy platform. The company's top-line growth is dependent on TomoTherapy system sales.